The extension for continued listing on Nasdaq is a positive development for Nemaura Medical, as it alleviates immediate delisting concerns and provides the company with time to work on meeting the exchange's requirements. This news is likely to be viewed positively by investors and could lead to a short-term increase in the stock price, reflecting relief and renewed confidence in the company's ability to maintain its listing status.